Physician

Paul M Gallogly, MD

According to 2025 Medicare claims, Paul Gallogly, MD (NPI: 1477500791) practices ophthalmology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is RETINA CARE SPECIALISTS PLLC (NPI: 1912192139; TIN: 20-8005671) and primary practice location at 33410-2809.

Gallogly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,521 traditional Medicare patients, billed 105,254 HCPCS/CPT codes, and received $4,819,576 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 726 prescription claims across 176 beneficiaries totaling $46,689 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 33 records totaling $4,565. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.8M2015 Medicare payment: $3,410,029 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,643,402 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,874,959 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,103,009 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,050,132 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,753,139 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,951,060 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,974,629 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,471,724 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,819,576 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,39121,245$3,410,029
20161,38522,284$3,643,402
20171,39822,762$3,874,959
20181,42923,497$4,103,009
20191,38224,399$4,050,132
20201,31919,903$3,753,139
20211,45520,474$3,951,060
20221,51225,724$3,974,629
20231,52275,609$4,471,724
20241,521105,254$4,819,576

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$31K$63K2015 Drug cost: $39,204 (USD; Tot_Drug_Cst)2016 Drug cost: $43,924 (USD; Tot_Drug_Cst)2017 Drug cost: $45,862 (USD; Tot_Drug_Cst)2018 Drug cost: $46,196 (USD; Tot_Drug_Cst)2019 Drug cost: $62,754 (USD; Tot_Drug_Cst)2020 Drug cost: $58,313 (USD; Tot_Drug_Cst)2021 Drug cost: $56,193 (USD; Tot_Drug_Cst)2022 Drug cost: $51,732 (USD; Tot_Drug_Cst)2023 Drug cost: $56,058 (USD; Tot_Drug_Cst)2024 Drug cost: $46,689 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015112502$39,204
2016123550$43,924
2017114545$45,862
2018128504$46,196
2019137579$62,754
2020137500$58,313
2021148593$56,193
2022153626$51,732
2023170644$56,058
2024176726$46,689

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5332,685$96
92014Established patient complete exam of visual system1,2661,849$95
92012Established patient problem focused exam of visual system6751,167$68
92134Imaging of retina1,4664,147$31
92250Photography of the retina7581,146$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium211,286$9,309
IlevroNepafenac14990$7,566
Prednisolone AcetatePrednisolone Acetate1595,750$6,349
LumiganBimatoprost18715$6,000
Ketorolac TromethamineKetorolac Tromethamine1566,847$2,381

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$4,565Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$14,616US Retina LLC

FAQ

What Medicare data is available for Paul M. Gallogly, MD?

Tedicare shows public-source Medicare data for Paul M. Gallogly, MD (NPI 1477500791), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul M. Gallogly, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul M. Gallogly, MD?

Paul M. Gallogly, MD is linked to RETINA CARE SPECIALISTS PLLC (billing NPI 1912192139) in the available physician profile data.

Does Paul M. Gallogly, MD have Open Payments data?

Paul M. Gallogly, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.